Home › Cardiovascular Disease › Texas › Amarillo
Cardiovascular Disease clinical trials in Amarillo, TX
5 studies for Cardiovascular Disease are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Amarillo
- Clinical Trial Site, Amarillo
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Amarillo
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- PharmaTex Research, LLC, Amarillo
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RecruitingPhase 3
- PharmaTex Research LLC, Amarillo
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- San Francisco, CA18 studies
Other studies in Amarillo
- Obesity10 studies
- Heart Failure8 studies
- Non-Small Cell Lung Cancer8 studies
- Overweight7 studies
- Atherosclerosis6 studies
- Lung Cancer5 studies
- Blood Clots4 studies
- Atrial Fibrillation3 studies
- Digestive Diseases3 studies
- Colorectal Cancer3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.